Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine

<b><i>Background:</i></b> Anthracyclines such as doxorubicin remain a primary treatment for hematological malignancies and breast cancers. However, cardiotoxicity induced by anthracyclines, possibly leading to heart failure, severely limits their application. The pathological...

Full description

Bibliographic Details
Published in:	Antioxidants
Main Authors:	Irwin K. Cheah, Richard M. Y. Tang, Xiaoyuan Wang, Karishma Sachaphibulkij, Suet Yen Chong, Lina H. K. Lim, Jiong-Wei Wang, Barry Halliwell
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	ergothioneine doxorubicin cardiotoxicity anthracycline chemotherapy
Online Access:	https://www.mdpi.com/2076-3921/12/2/320

Similar Items

Cardiotoxicity of doxorubicin – causes, prevention, prospects
by: Paweł Wesołowski, et al.
Published: (2022-11-01)

The role of doxorubicin in the formation of cardiotoxicity is a consensus statement. Part II. Cardiotoxicity of doxorubicin unrelated to myocytes and cardioprotection strategy (review)
by: D. A. Andreev, et al.
Published: (2024-09-01)

The Role of Doxorubicin in the Formation of Cardiotoxicity – Generally Accepted Statement. Part I. Prevalence and Mechanisms of Formation (Review)
by: D. A. Andreev, et al.
Published: (2024-03-01)

Potential Roles of Melatonin in Doxorubicin-Induced Cardiotoxicity: From Cellular Mechanisms to Clinical Application
by: Tanawat Attachaipanich, et al.
Published: (2023-02-01)

Could Ergothioneine Aid in the Treatment of Coronavirus Patients?
by: Irwin K. Cheah, et al.
Published: (2020-07-01)

microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in Mice
by: John Henderson, et al.
Published: (2021-08-01)

The beneficial role of exercise in preventing doxorubicin-induced cardiotoxicity
by: Samantha L. Gaytan, et al.
Published: (2023-03-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Prevention and management of anthracycline induced cardiotoxicity: A review
by: Ian Osoro, et al.
Published: (2022-12-01)

Temporal Dynamics of Extracellular Matrix Remodeling in Anthracycline-Induced Cardiotoxicity
by: Fibi Meshrkey, et al.
Published: (2025-09-01)

Cardioprotective potential of botanical agents against anthracycline-induced cardiotoxicity
by: Parisa Firoozbakhsh, et al.
Published: (2024-05-01)

Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician
by: Ekaterina Yu Podyacheva, et al.
Published: (2021-06-01)

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity
by: Becky Meiners, et al.
Published: (2018-08-01)

Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity
by: Himani Kumari, et al.
Published: (2020-05-01)

Systemic and cardiac susceptibility of immune compromised mice to doxorubicin
by: Amanda J. Favreau-Lessard, et al.
Published: (2019-04-01)

The risk of peripartum cardiomyopathy among pediatric, adolescent, and young adult cancer patients exposed to doxorubicin: an opinion article
by: Christina Carfagnini, et al.
Published: (2024-11-01)

Cardiac events among patients with sarcoma treated with doxorubicin by method of infusion: A real‐world database study
by: Lee D. Cranmer, et al.
Published: (2023-01-01)

Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans
by: Caroline J. Zeiss, et al.
Published: (2019-08-01)

Recent Advances in the Mechanisms of Cell Death and Dysfunction in Doxorubicin Cardiotoxicity
by: Tian-Hu Wang, et al.
Published: (2023-11-01)

Lipidomics application to explain acute cardiotoxicity induced by doxorubicin
by: Lubna Zuhair Abdul Karim, et al.
Published: (2019-12-01)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
by: Sebahat Ulusan, et al.
Published: (2023-05-01)

Investigation of the efficacy of tyrosol on doxorubicin-induced acute cardiotoxicity in rats
by: Mustafa Cellat, et al.
Published: (2022-09-01)

The Role of miRNAs in Chemotherapy-Induced Cardiotoxicity
by: Maria Anastasiou, et al.
Published: (2025-09-01)

Electrocardiographic characteristics of Nigerian children on anthracycline-based chemotherapy: A preliminary report
by: I D Peter, et al.
Published: (2017-01-01)

Therapeutic Potential of Ginsenosides in Anthracycline-Induced Cardiotoxicity
by: Rongrong Bai, et al.
Published: (2025-06-01)

Pharmacological interventions to prevent cardiotoxicity in patients undergoing anthracycline-based chemotherapy: a network meta-analysis
by: Xiaoyu Liu, et al.
Published: (2025-09-01)

Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons
by: Damien Meng-Kiat Leow, et al.
Published: (2024-06-01)

Use of indicators of systolic and diastolic functions of the left ventricle in the diagnosis of early cardiotoxicity during chemotherapy with doxorubicin: An open, prospective, nonrandomized study
by: Irina A. Karputs, et al.
Published: (2024-08-01)

Anthracycline-induced cardiotoxicity – primary preventive options. An overview
by: S. Slavcheva
Published: (2024-05-01)

Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al.

Cardiotoxicity: Importance of biomarkers
by: Kostadinović Jelena, et al.
Published: (2023-01-01)

Demystifying the Relationship Between Metformin, AMPK, and Doxorubicin Cardiotoxicity
by: Manrose Singh, et al.
Published: (2022-01-01)

Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in an Elderly Cohort Attending Memory Clinics
by: Liu-Yun Wu, et al.
Published: (2022-08-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01)

Is Electrocardiogram Helpful in Predicting a Rise in Troponin I as a Marker of Anthracycline Cardiotoxicity?
by: Kader Muneer, et al.
Published: (2022-10-01)

Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity
by: Sibren Haesen, et al.
Published: (2024-01-01)

Echocardiographic strategy for early detection of cardiotoxicity of doxorubicin: a prospective observational study
by: Diogo Pereira Santos Sampaio, et al.
Published: (2022-10-01)

Beneficial Effects of Oral Carbon Monoxide on Doxorubicin‐Induced Cardiotoxicity
by: Rodrigo W. Alves de Souza, et al.
Published: (2024-05-01)

Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
by: Maria Isabel Camara Planek, et al.
Published: (2020-07-01)

Cardiotoxicity of doxorubicin: Causes, diagnosis, consequences and possibilities of prevention
by: Radić Jelena P., et al.
Published: (2022-01-01)